Revenue: The sum of all revenue fields included for a company's operating activities.
Vanda Pharmaceuticals Inc. (VNDA) had Revenue of $50.04M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$50.04M |
$-29.49M |
|
$3.52M |
|
$46.52M |
|
$91.07M |
|
$-41.03M |
|
$3.66M |
|
$-37.37M |
|
$-37.37M |
|
$-29.49M |
|
$-29.49M |
|
$-29.49M |
|
$-29.49M |
|
$-41.03M |
|
$-39.79M |
|
58.53M |
|
58.53M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$407.91M |
|
$2.44M |
|
$224.03M |
|
$631.94M |
|
$103.92M |
|
-- |
|
$16.60M |
|
$120.52M |
|
$511.42M |
|
$399.07M |
|
$511.42M |
|
58.93M |
|
| Cash Flow Statement Financials | |
$-33.15M |
|
$43.90M |
|
$-1.32M |
|
$102.78M |
|
$112.27M |
|
$9.48M |
|
$2.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
92.96% |
|
-81.99% |
|
-81.99% |
|
-- |
|
-74.67% |
|
-58.94% |
|
$-33.58M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
1.83 |
|
1.12 |
|
80.22 |
|
-5.77% |
|
-7.39% |
|
-4.67% |
|
-5.77% |
|
$8.68 |
|
$-0.57 |
|
$-0.57 |
|